GLP-1 Receptor Agonists: Metabolic Effects and Their Role in Managing T2DM (webcourse)

Format: Webcourse

Credit(s): 1.00 (60 min)

Release Date: Aug 30, 2022

Expiration Date: Aug 30, 2023

Credit Type(s):

Physicians – AMA PRA Category 1 Credit(s) ™
Physicians – prescribed AAFP Credit(s)
Physicians/ABIM MOC – ABIM MOC Point(s)
Physician Assistants – AAPA Category 1 CME
Nurse Practitioners – contact hour(s) of continuing education

PROGRAM OVERVIEW

Based on the wide-ranging beneficial effects of GLP-1 RAs, the management of T2DM is no longer based on glucose control alone. The most recent ADA guidelines for T2DM provide guidance on drug- and patient-specific factors to consider when selecting an antihyperglycemic agent and therapeutic algorithms that center on a patient’s cardiovascular and renal profiles.

GLP-1 Receptor Agonists: Metabolic Effects and Their Role in Managing T2DM will inform clinicians about the pleiotropic effects of GLP-1 RAs, the demonstrated clinical efficacy of these agents for managing patients with T2DM and a variety of comorbid conditions, and guideline recommendations for incorporating GLP-1 RAs into management strategies for T2DM.